University of Chicago Comprehensive Cancer Center

The University of Chicago Medicine Comprehensive Cancer Center is a collaborative cancer research center based in Hyde Park, Chicago, United States.

He also serves as Biological Sciences Division Dean for Oncology and Professor of Obstetrics and Gynecology at the University of Chicago.

Comprehensive Cancer Center investigators are organized into four integrated scientific programs that take advantage of resources throughout the university, the University of Chicago Medical Center, and other scientific and medical communities: The Comprehensive Cancer Center is involved in more than 300 cancer clinical trials[6] and encourages participation in the clinical trials by community oncologists and minority populations through a network of affiliated hospitals.

Researchers also strive to eliminate health disparities among ethnic and social groups that compose areas surrounding the UChicago campus.

UChicago accomplishments include landmark prostate cancer treatment in 1939, the identification of the first chromosomal abnormality in leukemia in 1972, the 1988 discovery of the molecular mechanism by which tamoxifen blocks the effects of estrogen, and the 2008 development of a new MRI procedure that can detect early breast cancer.